Therapeutic administration of αGITR to established GBM tumors (GL261-MGH, CT2A, and 005GSC) (Fig. 2m) neither changed the Treg cell frequency (Fig. 2n) nor down-regulated FoxP3 expression (Fig. 2o). Here, FOXP3 is linked to glioblastoma.